Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19: fighting the invisible enemy with microRNAs
Neeraj Chauhan, Meena Jaggi, Subhash C. Chauhan, et al.
Expert Review of Anti-infective Therapy (2020) Vol. 19, Iss. 2, pp. 137-145
Open Access | Times Cited: 80

Showing 1-25 of 80 citing articles:

SARS-CoV-2-Specific Immune Response and the Pathogenesis of COVID-19
Evgeni Gusev, Alexey Sarapultsev, Л. В. Соломатина, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1716-1716
Open Access | Times Cited: 221
Biomarkers for Prognosis and Treatment Response in COVID-19 Patients
Giulia Bivona, Luisa Agnello, Marcello Ciaccio
Annals of Laboratory Medicine (2021) Vol. 41, Iss. 6, pp. 540-548
Open Access | Times Cited: 136
Metal‐Organic Frameworks for Gene Therapy and Detection
Ya‐Ping He, Daifeng Li, Li Wu, et al.
Advanced Functional Materials (2023) Vol. 33, Iss. 12
Closed Access | Times Cited: 49
miRNAs; a novel strategy for the treatment of COVID‐19
Ying Hao, Mohsen Ebrahimi, Mona Keivan, et al.
Cell Biology International (2021) Vol. 45, Iss. 10, pp. 2045-2053
Open Access | Times Cited: 78
The Role of miRNAs in COVID-19 Disease
Mona Fani, Milad Zandi, Saeedeh Ebrahimi, et al.
Future Virology (2021) Vol. 16, Iss. 4, pp. 301-306
Open Access | Times Cited: 69
Neuroinflammation and Its Impact on the Pathogenesis of COVID-19
Mohammed M. Almutairi, Farzane Sivandzade, Thamer H. Albekairi, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 63
Recent trends in miRNA therapeutics and the application of plant miRNA for prevention and treatment of human diseases
Atiyabanu N. Saiyed, Abhay R. Vasavada, Kaid Johar
Future Journal of Pharmaceutical Sciences (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 50
Mucormycosis and COVID-19 pandemic: Clinical and diagnostic approach
Asim Azhar, Wajihul Hasan Khan, Parvez Anwar Khan, et al.
Journal of Infection and Public Health (2022) Vol. 15, Iss. 4, pp. 466-479
Open Access | Times Cited: 40
Mesenchymal Stem Cell-Derived Extracellular Vesicles Carrying miRNA as a Potential Multi Target Therapy to COVID-19: an In Silico Analysis
Iago Carvalho Schultz, Ana Paula Santin Bertoni, Márcia Rosângela Wink
Stem Cell Reviews and Reports (2021) Vol. 17, Iss. 2, pp. 341-356
Open Access | Times Cited: 54
Role of microRNAs in COVID-19 with implications for therapeutics
Nahid Arghiani, Tracy Nissan, Maryam Moghaddam Matin
Biomedicine & Pharmacotherapy (2021) Vol. 144, pp. 112247-112247
Open Access | Times Cited: 54
A Timely Review of Cross-Kingdom Regulation of Plant-Derived MicroRNAs
Dan Li, Jianhui Yang, Yong Yang, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 51
Circulating plasma miR-155 is a potential biomarker for the detection of SARS-CoV-2 infection
Riham Abdel‐Hamid Haroun, Waleed H. Osman, Rasha E. Amin, et al.
Pathology (2021) Vol. 54, Iss. 1, pp. 104-110
Open Access | Times Cited: 48
Complement Mediated Hemolytic Anemias in the COVID-19 Era: Case Series and Review of the Literature
Bruno Fattizzo, Raffaella Pasquale, Valentina Bellani, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 42
MiRNA-SARS-CoV-2 dialogue and prospective anti-COVID-19 therapies
Mamta Panda, Elora Kalita, Satyendra Singh, et al.
Life Sciences (2022) Vol. 305, pp. 120761-120761
Open Access | Times Cited: 37
The regulation of lncRNAs and miRNAs in SARS-CoV-2 infection
Yuhao Lin, Qiqi Sun, Bao Zhang, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 17
Prediction and analysis of microRNAs involved in COVID-19 inflammatory processes associated with the NF-kB and JAK/STAT signaling pathways
Zeinab Amini‐Farsani, Mahtab Yadollahi‐Farsani, Samaneh Arab, et al.
International Immunopharmacology (2021) Vol. 100, pp. 108071-108071
Open Access | Times Cited: 36
A Transcription Regulatory Sequence in the 5′ Untranslated Region of SARS-CoV-2 Is Vital for Virus Replication with an Altered Evolutionary Pattern against Human Inhibitory MicroRNAs
Manijeh Mohammadi‐Dehcheshmeh, Sadrollah Molaei Moghbeli, Samira Rahimirad, et al.
Cells (2021) Vol. 10, Iss. 2, pp. 319-319
Open Access | Times Cited: 31
Efficient and Versatile Application of Fluorescence DNA-Conjugated CdTe Quantum Dots Nanoprobe for Detection of a Specific Target DNA of SARS Cov-2 Virus
Ghasem Rezanejade Bardajee, Mohammad Reza Zamani, Mahdieh Sharifi
Langmuir (2021) Vol. 37, Iss. 33, pp. 10223-10232
Closed Access | Times Cited: 28
Cytokine storm in the pathophysiology of COVID-19: Possible functional disturbances of miRNAs
Mona Aslani, Seyed Shahabeddin Mortazavi‐Jahromi, Abbas Mirshafiey
International Immunopharmacology (2021) Vol. 101, pp. 108172-108172
Open Access | Times Cited: 27
Mesenchymal Stem Cell-Derived Exosome Therapy of Microbial Diseases: From Bench to Bed
Xiaolan Wu, Shanshan Jin, Chengye Ding, et al.
Frontiers in Microbiology (2022) Vol. 12
Open Access | Times Cited: 21
Cardiovascular Implications of microRNAs in Coronavirus Disease 2019
Carmine Izzo, Valeria Visco, Jessica Gambardella, et al.
Journal of Pharmacology and Experimental Therapeutics (2022) Vol. 384, Iss. 1, pp. 102-108
Open Access | Times Cited: 21
miRNAs: The Key Regulator of COVID-19 Disease
Leyla Tahrani Hardin, Nan Xiao
International Journal of Cell Biology (2022) Vol. 2022, pp. 1-19
Open Access | Times Cited: 20
Thrombosis-related circulating miR-16-5p is associated with disease severity in patients hospitalised for COVID-19
Ceren Eyileten, Zofia Wicik, Sérgio Nery Simões, et al.
RNA Biology (2022) Vol. 19, Iss. 1, pp. 963-979
Open Access | Times Cited: 19
Host cell entry mediators implicated in the cellular tropism of SARS‑CoV‑2, the pathophysiology of COVID‑19 and the identification of microRNAs that can modulate the expression of these mediators (Review)
Periklis Katopodis, Harpal S. Randeva, Demetrios�� Spandidos, et al.
International Journal of Molecular Medicine (2021) Vol. 49, Iss. 2
Open Access | Times Cited: 26
Nanoparticulate Strategies for The Delivery of miRNA Mimics and Inhibitors in Anticancer Therapy and its Potential Utility in Oral Submucous Fibrosis
Jyothsna Manikkath, Padacherri Vethil Jishnu, Peter Wich, et al.
Nanomedicine (2022) Vol. 17, Iss. 3, pp. 181-195
Closed Access | Times Cited: 18
Page 1 - Next Page

Scroll to top